GlassScriptPhysician profile
Norah Owino
NPI 1467032706
$5,935.79
in general payments reported to CMS, 2019-2025
22 companies · $3,175 in 2025
The $3,175 reported for 2025 was more than what 97% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $14.05 · 2024: $2,582 · 2025: $3,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,669 · Travel and Lodging: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,668.90 |
| Travel and Lodging | $1,088.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,694.66 | 2024-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,125.83 | 2024-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,070.46 | 2021-2025 | Breztri, Airsupra, Fasenra |
| Genzyme Corporation | $401.07 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $342.38 | 2024-2025 | Dupixent |
| Verona Pharma, INC. | $334.15 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $275.50 | 2024-2025 | Aralast, Glassia |
| Actelion Pharmaceuticals US, INC. | $181.37 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Azurity Pharmaceuticals, INC. | $69.84 | 2024-2025 | Horizant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.62 | 2025 | Ofev, Jascayd |
| Mylan Specialty L.P. | $55.59 | 2024 | Yupelri |
| Insmed, INC. | $48.63 | 2025 | Arikayce |
| Viatris Specialty LLC | $41.20 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $40.00 | 2024 | Nuzyra |
| Philips North America LLC | $39.97 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $38.29 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Jazz Pharmaceuticals INC. | $34.31 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $18.42 | 2024 | Xarelto |
| Grifols USA, LLC | $16.87 | 2025 | Prolastin-C Liquid |
| Avadel Cns Pharmaceuticals, LLC | $15.93 | 2025 | Lumryz |
| Fresenius USA Marketing, INC. | $14.65 | 2021 | |
| Vifor Pharma, INC. | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norah Owino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.